[HTML][HTML] Androgen receptor expression predicts different clinical outcomes for breast cancer patients stratified by hormone receptor status
HS Jiang, XY Kuang, WL Sun, Y Xu, YZ Zheng… - Oncotarget, 2016 - ncbi.nlm.nih.gov
In this study we sought to correlate androgen receptor (AR) expression with tumor
progression and disease-free survival (DFS) in breast cancer patients. We investigated AR …
progression and disease-free survival (DFS) in breast cancer patients. We investigated AR …
Transcriptome‐wide association study of breast cancer risk by estrogen‐receptor status
Previous transcriptome‐wide association studies (TWAS) have identified breast cancer risk
genes by integrating data from expression quantitative loci and genome‐wide association …
genes by integrating data from expression quantitative loci and genome‐wide association …
[HTML][HTML] Poorer breast cancer survival outcomes in males than females might be attributable to tumor subtype
Q Wu, J Li, S Zhu, J Wu, X Li, Q Liu, W Wei, S Sun - Oncotarget, 2016 - ncbi.nlm.nih.gov
Methods Using data obtained by the Surveillance, Epidemiology, and End Results (SEER)
program from 2010-2012, a retrospective, population-based cohort study was conducted to …
program from 2010-2012, a retrospective, population-based cohort study was conducted to …
Subtype-specific risk factors for postmenopausal breast cancer: findings from the PLCO trial
O Abdel-Rahman, PA Tang, WY Cheung - Clinical and Translational …, 2020 - Springer
Objective The aim of this analysis is to evaluate the relative weight of different
epidemiological risk factors on the development of different breast cancer subtypes (ie …
epidemiological risk factors on the development of different breast cancer subtypes (ie …
Tumor subtypes and survival in male breast cancer
J Leone, RA Freedman, NU Lin, SM Tolaney… - Breast Cancer Research …, 2021 - Springer
Purpose Male breast cancer is an uncommon disease, and population-based information
regarding prognostic factors is limited. Most cases are hormone receptor (HR) positive; …
regarding prognostic factors is limited. Most cases are hormone receptor (HR) positive; …
Androgen receptor expression inversely correlates with histological grade and N stage in ER+/PgRlow male breast cancer
Abstract Purpose Androgen Receptor (AR) positivity is often displayed in breast cancer and
especially in Male Breast Cancer (MBC), where it appears to be a heterogeneous feature …
especially in Male Breast Cancer (MBC), where it appears to be a heterogeneous feature …
[引用][C] Lost in translation? Estrogen receptor status and endocrine responsiveness in breast cancer.
N Harbeck, A Rody - Journal of clinical oncology: official journal of …, 2012 - europepmc.org
Lost in translation? Estrogen receptor status and endocrine responsiveness in breast cancer. -
Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About …
Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About …
Only estrogen receptor “positive” is not enough to predict the prognosis of breast cancer
JM Ryu, HJ Choi, I Kim, SK Lee, J Yu, JE Kim… - Breast Cancer Research …, 2018 - Springer
Purpose Beginning in 2018, biomarkers including estrogen receptor (ER) status were
incorporated in the 8th AJCC staging system. ER expression levels were not considered in …
incorporated in the 8th AJCC staging system. ER expression levels were not considered in …
[HTML][HTML] AR negative triple negative or “quadruple negative” breast cancers in African American women have an enriched basal and immune signature
There is increasing evidence that Androgen Receptor (AR) expression has prognostic
usefulness in Triple negative breast cancer (TNBC), where tumors that lack AR expression …
usefulness in Triple negative breast cancer (TNBC), where tumors that lack AR expression …
Combined androgen and estrogen receptor status in breast cancer: treatment prediction and prognosis in a population-based prospective cohort
K Elebro, S Borgquist, M Simonsson, A Markkula… - Clinical cancer …, 2015 - AACR
Purpose: To evaluate whether tumor androgen receptor (AR) expression was prognostic
and/or predictive for endocrine treatment alone or in combination with estrogen receptor …
and/or predictive for endocrine treatment alone or in combination with estrogen receptor …